General Resources
These resources relate to the issues that MeTA is concerned with, both internally and externally produced. Clicking on one of the links may take you away from the MeTA website, to the source of that information.
Elsevier admits journal error
The world’s leading scientific publisher, fails to meet its own transparency standards with publication sponsored by Merck, but presented as independent academic journal.
How the counterfeit bill can negatively affect access to medicines in Uganda
Uganda largely depends on generic medication to treat the sick, but a new Counterfeit Bill may put a stop to the cheaper drugs.
Benchmarking antiretroviral prices in countries of the former Soviet Union
A study comparing the price of antiretroviral medicines in the former Soviet Union with prices in elsewhere in Europe and globally.
ASEAN ministers sign drug accord
ASEAN Economic Ministers sign deal on safety, quality, efficacy and lower prices of drugs sold in the region - Philippine Daily Inquirer
Edinburgh to be the first British university to help make medicines cheaper in developing world
Edinburgh will be the first British university to license research to pharmaceutical companies only on condition that poorer communities get life-saving drugs at cost price.
Malaria drugs cheaper in £150m deal to save lives
Up to 300,000 lives a year could be saved by a groundbreaking international deal that will slash the cost of medicines to fight malaria - The Guardian, UK
Procurement of contraceptives in Latin America and the Caribbean
This report summarises experiences and lessons learned while facing new procurement challenges in 14 countries in the Latin American and Caribbean region.
Merck follows up GSK challenge by donating malaria drug to non-profit group
Merck is donating an experimental anti-malarial medicine to a not-for-profit research organisation - Reuters
Decline in government financial transparency in the Philippines
The Open Budget Survey 2008, ranks the Philippines 34th and has a two point drop in the index used to measure transparency from when the survey was conducted two years ago.
Need for increased transparency in medicine regulation processes
Full transparency is needed for all steps in medicines' marketing, from the publication of trial protocols, to assessment of the data - Australian Prescriber editorial.